Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients
Cut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin · 2023
Read Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients by Cut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10919436.txt.
Description
Coronary artery disease (CAD) remains a significant global health concern with considerable high morbidity and mortality and its development is influenced by various genetic and environmental factors. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a vital regulator of low-density lipoprotein receptor (LDLR) metabolism, directly impacting serum cholesterol levels. However, its role in development of CAD is not fully understood.
Catalog record
| CREATOR | Cut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |